View in EDS PDF Full Text

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts.

Saved in:
Bibliographic Details
Title: Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts.
Authors: Ricci, Francesca1, Guffanti, Federica1, Damia, Giovanna1 damia@marionegri.it, Broggini, Massimo1
Source: Molecular Cancer. 5/30/2017, Vol. 16, p1-6. 6p. 2 Charts, 3 Graphs.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 123331578
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ricci%2C+Francesca%22">Ricci, Francesca</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Guffanti%2C+Federica%22">Guffanti, Federica</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Damia%2C+Giovanna%22">Damia, Giovanna</searchLink><relatesTo>1</relatesTo><i> damia@marionegri.it</i><br /><searchLink fieldCode="AR" term="%22Broggini%2C+Massimo%22">Broggini, Massimo</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Molecular+Cancer%22">Molecular Cancer</searchLink>. 5/30/2017, Vol. 16, p1-6. 6p. 2 Charts, 3 Graphs.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=123331578
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12943-017-0662-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 1
    Titles:
      – TitleFull: Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ricci, Francesca
      – PersonEntity:
          Name:
            NameFull: Guffanti, Federica
      – PersonEntity:
          Name:
            NameFull: Damia, Giovanna
      – PersonEntity:
          Name:
            NameFull: Broggini, Massimo
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 05
              Text: 5/30/2017
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-print
              Value: 14764598
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Molecular Cancer
              Type: main
ResultId 1